Immunohistochemical analysis of the local tumor microenvironment identified IDO expression in human dendritic cells (DCs) in melanoma (131), breast cancer (45), squamous cell carcinoma (132), Hodgkin lymphoma (71), and esophageal cancer (133). Here, IDO1 is linked to breast cancer.